- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Mankind Pharma has provided a report from CARE Ratings concerning the utilization of proceeds from its recently completed Qualified Institutions Placement (QIP) of ₹3,000 crore for the quarter ending December 31, 2024. The monitoring agency confirmed that there were no deviations in the use of funds from the stated objectives. As of the end of the quarter, ₹2,955.03 crore was transferred to term deposits, with a small balance remaining in the escrow account. This successful monitoring emphasizes strong financial management, potentially enhancing investor confidence in the company's strategic financial planning and operational integrity.